Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
—
—
—
—
—
—
1 Year
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
All Time
—
—
33%
—
—
Never
—
All Time
Score—
Net Growth—
Net Trend33%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
OKYO Pharma Ltd ADR fundamental performance
Across OKYO Pharma Ltd ADR's full reported history, from 2023 to 2026, revenue held from £ 0.00 to £ 0.00 and net income went from -£ 13M to -£ 8M. Revenue increased in 0% of the years measured; net income in 33%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.50 | — |
1 Year2025-08-12 | $ 2.96 | -49.20% |
All Time2022-05-17 | $ 3.62 | -58.43% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2022-05-17 |
|---|---|---|---|
| Price | $ 1.50 | $ 2.96 | $ 3.62 |
| Return | — | -49.20% | -58.43% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2027 | £ 20M | ||
| 2026 | £ 0.00 | -£ 8M | £ 20M |
| 2025 | £ 0.00 | -£ 4M | £ 1M |
| 2024 | £ 0.00 | -£ 16M | £ 826.85K |
| 2023 | £ 0.00 | -£ 13M | £ 4M |
Explore beyond OKYO
You're looking at OKYO Pharma Ltd ADR. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
